| dc.creator |
Matzinger, Oscar |
|
| dc.creator |
Heimsoth, Irma |
|
| dc.creator |
Gulyban, Akos |
|
| dc.creator |
Pierart, Marianne |
|
| dc.creator |
Van Tienhoven, Geertjan |
|
| dc.creator |
Poortmans, Philip |
|
| dc.creator |
Collette, Laurence |
|
| dc.creator |
Struikmans, Henk |
|
| dc.creator |
Van Den Bogaert, Walter |
|
| dc.creator |
Bartelink, Harry |
|
| dc.creator |
Fourquet, Alain |
|
| dc.creator |
Ataman, Fatma |
|
| dc.date |
2010-01-01T01:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:53:47Z |
|
| dc.date.available |
2021-12-03T11:53:47Z |
|
| dc.identifier |
b2561514-1687-4d03-8c99-45ad134f2e15 |
|
| dc.identifier |
10.3109/02841860903352959 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/b2561514-1687-4d03-8c99-45ad134f2e15/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/94355 |
|
| dc.description |
Introduction. The EORTC 22922/10925 trial investigated the potential survival benefit and toxicity of elective irradiation of the internal mammary and medial supraclavicular (IM-MS) nodes Accrual completed in January 2004 and first results are expected in 2012. We present the toxicity reported until year 3 after treatment. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925) |
|
| dc.type |
info:eu-repo/semantics/article |
|